Viewing Study NCT05144256


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-06-21 @ 3:36 PM
Study NCT ID: NCT05144256
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-28
First Post: 2021-11-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period
Sponsor: Agios Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pediatric Pyruvate Kinase Deficiency View
None Pediatric Hemolytic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anemia View
None Hematologic Diseases View
None Metabolic Diseases View
None Mitapivat View
None AG-348 View
None ACTIVATE-KidsT View
None PK Deficiency View